Study # SourSop

A Pilot Study of Soursop Tea in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)

Study Status:

Enrolling

Treatment Agent:

Soursop tea

Description

Short Title: Soursop

The study will determine if there is a reduction in malignant cell burden when patients with relapsed and/or refractory acute myeloid leukemia (AML) or multiple myeloma (MM) consume tea made from the dried leaves of Annona muricata (Soursop). The study goal is to determine the safety and anti-neoplastic efficacy of Annona muricata tea when taken in escalating frequency over a period of 21 days by patients with relapsed/refractory AML or MM for whom there are no standard therapeutic options.

Resources and Links

National Clinical Trial Identified Number: Not available at this time

Information and next steps

Disease:

  • Acute Myeloid Leukemia ,
  • Multiple Myeloma

Study Phase:

Not applicable

Physician Name:

Department:

Ask a Question